SCHEMBL28156717

SCHEMBL28156717

CS(=O)(=O)c1ccc(NC(=O)c2ccccc2F)s1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ SMN1; SMN2 Q16637 5/20 0.49
▸ GAA P10253 2/20 0.47
▸ LMNA P02545 2/20 0.47
▸ RAB9A P51151 7/20 0.46
▸ NPC1 O15118 6/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.46
▸ HTT P42858 2/20 0.45
▸ TP53 P04637 2/20 0.45
▸ PKM P14618 1/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ HPGD P15428 1/20 0.44
▸ POLB P06746 3/20 0.44
▸ CASP3 P42574 1/20 0.43
▸ SENP7 Q9BQF6 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ NFKB1 P19838 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28157305 0.86 MEN1 (0.48) MEN1KMT2ATDP1SMN1; SMN2GAA
SCHEMBL28846257 0.85 MEN1 (0.47) MEN1KMT2ATDP1SMN1; SMN2GAA
SCHEMBL28156725 0.84 NPC1 (0.47) MEN1KMT2ASMN1; SMN2GAALMNA
SCHEMBL28846379 0.84 HPGD (0.52) MEN1KMT2ATDP1SMN1; SMN2GAA
SCHEMBL28156718 0.84 KAT6A (0.50) MEN1KMT2ATDP1SMN1; SMN2GAA
SCHEMBL28157364 0.82 LMNA (0.45) MEN1KMT2ATDP1SMN1; SMN2GAA
SCHEMBL28156742 0.82 LMNA (0.52) MEN1KMT2ATDP1SMN1; SMN2LMNA
SCHEMBL28846263 0.80 SMN1; SMN2 (0.42) MEN1KMT2ATDP1SMN1; SMN2GAA
SCHEMBL28156720 0.80 MAPT (0.64) MEN1KMT2ASMN1; SMN2GAALMNA
SCHEMBL28157321 0.80 TP53 (0.44) MEN1KMT2ATDP1SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105531268-B Noval chemical compound and its pharmaceutical composition for treating cystic fibrosis 加拉佩格斯股份有限公司 2017-09-12 — — CN disclosed
Send feedback